Empery Asset Management LP 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-20 11:11 am Unchanged |
2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management LP | 44 4.990% |
0 (Unchanged) |
Filing |
| 2020-11-18 10:08 am Purchase |
2020-11-12 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management LP | 44 6.350% |
44 (New Position) |
Filing |